CartilaGen
Developing drug-eluting bioactive materials to treat articular cartilage damage and osteoarthritis.
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $25.0k | Grant | |
N/A | Grant | ||
* | N/A | N/A | Grant |
* | $125k | Grant | |
Total Funding | AUD232k |
Related Content
Recent News about CartilaGen
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.